Tag: Umbralisib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Umbralisib

TG Therapeutics Initiates Rolling Submission of Biologics License Application to US Food and ...

Added to Collection on: 2020-12-01 13:30:00

Tags for this article:

Drugs
Clinical medicine
Cancer treatments
Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Chronic lymphocytic leukemia
Obinutuzumab
Tyrosine kinase inhibitors
CD20
Umbralisib
Ibrutinib
TG Therapeutics Inc.
New York City
New York

Click the tags to see associated articles and topics

View Article Details
TG adds a multiple sclerosis string to its bow

Added to Collection on: 2020-12-11 15:45:00

Tags for this article:

Breakthrough therapy
Health sciences
Drugs
Chemical compounds
Ocrelizumab
Phosphoinositide 3-kinase inhibitor
Ofatumumab
Umbralisib
Venetoclax
Obinutuzumab
CD20
Biogen

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics set for upsized IPO to develop cancer combination drug

Added to Collection on: 2020-12-15 10:52:30

Tags for this article:

Breakthrough therapy
Drugs
Health sciences
Clinical medicine
Ofatumumab
Chronic lymphocytic leukemia
Umbralisib
Obinutuzumab
CD20
Leukemia
Ibrutinib
Roche

Click the tags to see associated articles and topics

View Article Details
D'Angelo Describes Innovative Combos Designed to Produce Durable Activity in Relapsed ...

Added to Collection on: 2021-03-09 20:15:00

Tags for this article:

Drugs
Clinical medicine
Orphan drugs
Medicine
Lymphoma
Non-Hodgkin lymphoma
Diffuse large B-cell lymphoma
Antineoplastic drugs
Rituximab
Tumors of the hematopoietic and lymphoid tissues
P110α
Umbralisib

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics Completes Rolling Submission of Biologics License Application to the US Food ...

Added to Collection on: 2021-03-29 11:37:30

Tags for this article:

Drugs
Clinical medicine
Health sciences
Orphan drugs
Breakthrough therapy
Chronic lymphocytic leukemia
Obinutuzumab
Leukemia
Umbralisib
CD20
Phosphoinositide 3-kinase inhibitor
P110α

Click the tags to see associated articles and topics

View Article Details
TG Therapeutics completes FDA filing for Roche challenger in CLL - - Pharmaphorum

Added to Collection on: 2021-03-30 11:11:28

Tags for this article:

Breakthrough therapy
Orphan drugs
Drugs
Health sciences
Clinical medicine
Obinutuzumab
Chronic lymphocytic leukemia
Umbralisib
Selinexor
ublituximab
Roche

Click the tags to see associated articles and topics

View Article Details
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in ...

Added to Collection on: 2021-04-10 18:33:45

Tags for this article:

Drugs
Health sciences
Life Sciences
Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Specialty drugs
Drug discovery
Phosphoinositide 3-kinase inhibitor
Verastem Oncology
Duvelisib
Umbralisib
Scott Fields

Click the tags to see associated articles and topics

View Article Details
Glofitamab by F. Hoffmann-La Roche for Chronic Lymphocytic Leukemia (CLL)

Added to Collection on: 2024-06-18 22:50:20

Tags for this article:

Lymphoma
Non-Hodgkin lymphoma
Orphan drugs
Diffuse large B-cell lymphoma
B-cell lymphoma
Chronic lymphocytic leukemia
Large-cell lymphoma
Umbralisib
Toralizumab

Click the tags to see associated articles and topics

View Article Details
Roche provides update on FDA Advisory Committee meeting on Columvi combination for ...

Added to Collection on: 2025-05-20 19:02:11

Tags for this article:

Lymphoma
Orphan drugs
Non-Hodgkin lymphoma
Antineoplastic drugs
Diffuse large B-cell lymphoma
Cancer treatments
Selinexor
Umbralisib

Click the tags to see associated articles and topics

View Article Details
Iopofosine-131 Earns FDA Breakthrough for Waldenstrom Macroglobulinemia - Cure Today

Added to Collection on: 2025-06-05 15:20:30

Tags for this article:

Orphan drugs
Food and Drug Administration
Pharmaceuticals policy
Pharmacy
Biotechnology law
Breakthrough therapy
Fast track
Priority review
Umbralisib

Click the tags to see associated articles and topics

View Article Details
Book a Demo